Fig. 9From: CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancersClinical value of CEP55 expression in LUSC. Panels A–B: CEP55 distinguishes LUSC well from control tissues. Panels C–D: The correlation of CEP55 expression with the overall survival of LUSC patients; the red curve represents the high-CEP55 expression group, while the blue curve represents the low-CEP55 expression groupBack to article page